Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Psychedelics Weekly – New LSD Research and The Challenges Facing a...

Sunstone Therapies presents data at ASCO showing positive long-term follow-up results...

Terran Biosciences announces new breakthroughs in the chemistry of MDMA and...

Data Demonstrating Long-Term Improvement in Depression in Cancer Patients Following Single...

Small Pharma Announces Significant Developments In Intellectual Property Portfolio

Numinus Aligns Business Initiatives to Prepare for Future Approval of MDMA-Assisted...

PT411 – The Humanity of Healthcare Professionals, Ancient Psychedelic Use, and...

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Clearmind Medicine Announces First US Site for its Phase I/IIa Clinical...

Psychedelics Weekly – Challenging the ‘Gifting’ Part of Prop 122, Public...

1...656667...218 Page 66 of 218

AtaiBeckley Posts Positive Phase 2b Open-Label Extension Data for 5-MeO-DMT, Plots...

Pα+ Psychedelic Bulletin #213: Compass Accelerates Psilocybin Launch Planning; Australian VA...

Review: Colorado Psychedelic Cup 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin